Bromfenac
| CAS No. | 91714-94-2 |
|---|---|
| MDL No. | MFCD00864341 |
| MF | C15H12BrNO3 |
| MW | 334.16 |
| InChI Key | ZBPLOVFIXSTCRZ-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Bromfenac is amfenac with the hydrogen at the 4-position of the benzoyl group replaced by bromine. It is used for managing ocular pain and treating postoperative inflammation after cataract surgery. Withdrawn from the US market in 1998 due to concerns over off-label abuse and hepatic failure, it functions as a non-steroidal anti-inflammatory drug and non-narcotic analgesic. It belongs to benzophenones, substituted anilines, aromatic amino acids, and organobromine compounds. It is functionally related to amfenac and is the conjugate acid of bromfenac(1-).
| CAS No. | 91714-94-2 |
|---|---|
| Product Name | Bromfenac |
Biological Targets
PTGS2·PTGS1
Associated Conditions
Ocular pain·cataract·age-related macular degeneration·inflammation·presbyopia·
* The information provided here is compiled from public sources and is for reference only.
